Multiple sclerosis (MS) is a common neurological disorder causing disability in young people in the developed world, with approximately 2 million people affected by the condition worldwide and 100,000 people affected in the UK(McAlpine and Compston 2005). MS is a progressive illness with neuroinflammatory and neurodegenerative components generally accepted to have an underlying auto-immune aetiology.
|Title of host publication||Neurological Rehabilitation: Spasticity and Contractures in Clinical Practice and Research.|
|Editors||Anand Pandanyan, Hermie J. Hermens, Bernard A. Conway|
|Place of Publication||Florida, USA|
|Number of pages||28|
|Publication status||Published - May 2018|
|Name||Rehabilitation Science in Practice Series|
- multiple sclerosis
- clinical management
Paul, L., & Mattison, P. (2018). Clinical management of spasticity and contractures In multiple sclerosis. In A. Pandanyan, H. J. Hermens, & B. A. Conway (Eds.), Neurological Rehabilitation: Spasticity and Contractures in Clinical Practice and Research. (1st ed., pp. 175-202). (Rehabilitation Science in Practice Series). CRC Press.